Showing results (91-100 of 192) with videos related to

Sort By:
Pageof 20
Internal Medicine Journal|January 10, 2018
Drug-induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitalsWendy C Fang, Nikki R Adler, Linda V Graudins, et al.
Journal of Hepatology|April 22, 2021
Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitisGeraldine J Ooi, Peter J Meikle, Kevin Huynh, et al.
International Journal of Obesity (2005)|February 22, 2018
Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesityGeraldine J Ooi, Arul Earnest, William W Kemp, et al.
Journal of Hepatology|May 1, 2018
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis CStephen Bloom, William Kemp, Amanda Nicoll, et al.
Obesity Surgery|August 5, 2017
Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in ObesityGeraldine J Ooi, Paul R Burton, Arul Earnest, et al.
Scandinavian Journal of Gastroenterology|January 24, 2015
Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian studyIlana Gory, Michael Fink, Sally Bell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 31, 2022
Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trialElena S George, Anjana Reddy, Amanda J Nicoll, et al.
Expert Opinion on Drug Safety|September 5, 2012
Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studiesPatrick Marcellin, Stuart K Roberts, K Rajender Reddy, et al.
The Medical Journal of Australia|December 14, 2020
Australian recommendations for the management of hepatocellular carcinoma: a consensus statementJohn S Lubel, Stuart K Roberts, Simone I Strasser, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1William Sievert, Gregory J Dore, Geoffrey W McCaughan, et al.
Pageof 20